Topics & News
-
open_in_newTakanori ABE will give a speech at session titled Pharma III "Walking on the Fence - Navigating Collaborations in Biopharma" at AIPPI World Congress.
-
NEWIn IAM Patent 1000 2025, ABE & PARTNERS is highly evaluated as follows; “Abe & Partners is a great, client-friendly and responsive firm with a very good work ethic. Even though they are not big, they get the work done. They tailor the advice to the client’s commercial goal, and work hard to understand the complex technology. Their English capability is excellent.” Abe & Partners is an Osaka-based general law practice with impressive IP capabilities. The outfit’s compact team has extensive technical expertise, excelling in fields such as pharmaceuticals, chemistry and technology. Dual qualified in Japan and New York, managing partner Takanori Abe is a seasoned litigator with ample international experience, which comes in handy when dealing with cross-border matters. He routinely represents some of the world’s leading companies - often in the life sciences - in complex courtroom battles where there is a lot at stake. “Takanori is a brilliant attorney and a powerhouse. He never gave up, although the case was extraordinarily difficult. His energy contributed a lot to the final settlement”, says a source connected to a recent, non-disclosable matter.
-
open_in_new NEWTakanori ABE was selected as SILVER by IAM Patent 1000 2025 in the category of Litigation.
-
open_in_new NEWABE & PARTNERS was selected as BRONZE by IAM Patent 1000 2025 in the category of Litigation.
-
German Law & Patent Firm has visited ABE & PARTNERS.
-
Takanori ABE gave a lecture entitled "Medical Standard of Care" at Faculty of Medicine, Osaka University.
-
German Law & Patent Firm has visited ABE & PARTNERS.
-
Netherlands Law & Patent Firm has visited ABE & PARTNERS.
-
open_in_newABE & PARTNERS was selected as a finalist for ALB Japan Law Award 2025 in the category of Rising Law Firm of the Year.
-
open_in_newABE & PARTNERS was selected as a finalist for ALB Japan Law Award 2025 in the category of Osaka Law Firm of the Year.
-
open_in_newABE & PARTNERS was selected as a finalist for ALB Japan Law Award 2025 in the category of Litigation Law Firm of the Year.
-
open_in_newABE & PARTNERS was selected as a finalist for ALB Japan Law Award 2025 in the category of Japan Intellectual Property Law Firm of the Year.
-
open_in_newABE & PARTNERS was selected as a finalist for ALB Japan Law Award 2025 in the category of Healthcare and Life Sciences Law Firm of the Year.
-
open_in_newABE & PARTNERS was selected as a finalist for ALB Japan Law Award 2025 in the category of Boutique Law Firm of the Year.
-
open_in_newTakanori ABE was selected as a finalist for ALB Japan Law Award 2025 in the category of Managing Partner of the Year.
-
open_in_newTakanori ABE was selected as a finalist for ALB Japan Law Awards 2025 in the category of Dispute Resolution Lawyer of the Year.
-
Takanori ABE was recognized by Industry Chronicle as Top 10 Inspiring Legal Leaders to Watch in 2025.
-
open_in_newTakanori ABE's interviewed article titled "Trailblazing Innovation: Takanori Abe's Visionary Leadership in Intellectual Property Law" had been published on Industry Chronicle.
-
ABE & PARTNERS was awarded BUSINESS EXCELLENCE AWARDS 2025 by BIZTECH OUTLOOK.
-
open_in_newTakanori ABE's interviewed article titled "ABE & PARTNERS: The Architects of Legal Innovation in a Borderless World" had been published on BIZTECH OUTLOOK.
-
Takanori ABE was recognized by Prime View Magazine as The Most Influential Legal Leaders to follow in 2025.
-
open_in_newTakanori ABE's interviewed article titled "A True Pioneer in Intellectual Property Law: Mr. Takanori ABE’s Empowering Journey" had been published on PRIME VIEW as The Most Influential Legal Leaders to Follow in 2025.
-
UK Law Firm has visited ABE & PARTNERS.
-
Our firm member enjoyed watching "American Manhunt: O.J. Simpson".
-
open_in_newABE & PARTNERS represented Regeneron Pharmaceuticals against Samsung Bioepis in an Unfair Competition PI Case and received a dismissal decision.
-
German Law & Patent Firm has visited ABE & PARTNERS.
-
UK Law Firm has visited ABE & PARTNERS.
-
open_in_newTakanori ABE gave a speech at AIPPI Pharma Webinar "What Discovery Mechanisms Exist in China, Japan, Korea, and India to Aid in the Preparation of a Preliminary Injunction (PI) Request or General Evidence Gathering?".
-
open_in_newABE & PARTNERS represented Bayer Healthcare against Samsung Bioepis in an Unfair Competition PI Case and received a dismissal decision.
-
US Law Firm has visited ABE & PARTNERS.
-
ABE & PARTNERS represented U.S. Pharmaceutical Company against X in Patent Opposition and received a decision to maintain the patent.
-
Takanori ABE gave a speech regarding Japanese pharmaceutical patent litigation at the client company (a pharmaceutical company, listed on the Prime Market of Tokyo Stock Exchange).
-
Takanori ABE gave a lecture entitled "How was Japanese patent litigation reformed" at Japan-China IP Conference organized by JAPIT.
-
open_in_newTakanori ABE's article titled "Patent royalty claim dismissed due to a demurrer, admitting the reach of an arbitration agreement - Defendants' measures and plaintiffs? risk reduction -" had been published on Japan Commercial Arbitration Journal Vol. 5 [2024].
-
Chinese Law Firm has visted ABE & PARTNERS.
-
ABE & PARTNERS represented Japanese Pharmaceutical Company against Indian Pharmaceutical Company in the Trial for Patent Invalidation for vaccine patent case and received invalidity decision.
-
Takanori ABE's comment appeared in an article titled "Avoiding disputes between university and industry, patent agreements are critical" in Yomiuri Newspaper.
-
Takanori ABE has been selected as IP Star 2024 by Managing Intellectual Property.
-
NEWTakanori ABE was selected as SILVER by IAM Patent 1000 2024 in the category of Litigation.
-
Takanori ABE gave a lecture entitled "Medical Standard of Care" at Faculty of Medicine, Osaka University.
-
open_in_newABE & PARTNERS has been ranked Tier2 in Japan Domestic, Patents by Asian Legal Business' ALB 2024 IP Ranking.
-
open_in_newTakanori ABE's interviewed article titled "Five minutes with…Takanori Abe, Abe & Partners" had been published on Managing Intellectual Property.
-
Singaporean Law Firm has visited ABE & PARTNERS.
-
Takanori ABE published the article titled "Amgen v Sanofi/Regeneron in Japan: Function, sequence, mechanism".
-
open_in_newTakanori ABE's article titled "Amgen v Sanofi/Regeneron in Japan: Function, sequence, mechanism" had been published on LSIPR.
-
German Law & Patent Firm has visited ABE & PARTNERS.
-
open_in_newTakanori ABE has been selected as Top 50 IP Experts of Japan 2024 by Asia IP.
-
open_in_newTakanori ABE gave a speech entitled "Amgen v. Sanofi/Regeneron in Japan" at the session "Amgen vs Sanofi/Regeneron” at Pharma & Biotech Patent Litigation Summit, Europe.
-
Takanori ABE published the article titled "Preliminary injunctions in pharmaceutical patent cases in Japan".
-
open_in_newTakanori ABE's article titled "Preliminary injunctions in pharmaceutical patent cases in Japan" had been published on LSIPR.
Archive